Asset evaluation

Establish the attractiveness, market viability, and likelihood of success for an internal or external asset at the earliest opportunity.

Power your strategic decision-making

with data-driven insights and collaborative consulting

Leverage our experience and expertise to establish your asset evaluation strategy, forecast clinical and launch success, and remain agile in an evolving market.

Cogni, your collaborative consulting platform, goes beyond the data with expert analysis and real-time recommendations tailored to your strategic imperatives.

Clinical landscaping 

  • Understand the attractiveness of, and demand for, a novel product within a given indication through analysis of the disease burden and unmet need  
  • Evaluate clinical treatment guidelines in order to establish current standard of care and potential market positioning
  • Determine market potential by assessing the size of the addressable population

Competitive landscaping

  • Recognize opportunities and potential scope for product differentiation through current and future competitive landscaping  
  • Inform development timelines and identify potential roadblocks
  • Review competitor regulatory approvals and Health Technology Assessment (HTA) evaluations to better understand the path to market approval and reimbursement

Market value and price benchmarking

  • Understand current pricing dynamics within your therapy area to provide insight into the market's willingness to pay
  • Examine pricing strategies of existing drugs to facilitate communication of your asset’s unique value proposition and help justify price expectations
  • Identify and mitigate potential risks associated with pricing pressures, such as competition from generics or biosimilars


  • Understand factors influencing likelihood of success for an asset in development  
  • Gauge market demand
  • Establish where and how an asset has the potential to address unmet needs and reduce disease burden
  • Optimize development and commercialization strategies for maximum impact and value creation
  • Identify potential market challenges and develop risk mitigation strategies
  • Inform strategic price decision-making and resource allocation

Contact us

All delivered as strategic reports, interactive intelligence dashboards and scenario planning tools, placing an optimal strategy at your fingertips.

Delivered through Cogni

Cogni by VISFO logo

consulting platform

  • High-impact strategic guidance built on a legacy of successful drug development and product launches

  • Bespoke knowledge management and collaboration software

  • Instant access to evolving outputs for quick report generation and sharing

A VISFO "Addressable patient population intelligence board" displayed on both a desktop and mobile screen. The board includes sections for "Interpretation" and "Activity", with fields for adding comments and viewing activity logs.